Experience of persistent psychological symptoms and perceived stigma among people with HIV on antiretroviral therapy (ART): A systematic review

International Journal of Nursing Studies

Volumn 51, Issue 8, 2014, Pages 1171-1189

  Lowther, Keira ^a   Selman, Lucy ^a   Harding, Richard ^a   Higginson, Irene J ^a  

^a KING'S COLLEGE LONDON   (United Kingdom)

Author keywords

Antiretroviral therapy; Anxiety; Depression; HIV AIDS; Stigma

Indexed keywords

ANTI HUMAN IMMUNODEFICIENCY VIRUS AGENT;

HIV INFECTIONS; HUMAN; PATIENT COMPLIANCE; PSYCHOLOGY; STEREOTYPING;

ANTI-HIV AGENTS; HIV INFECTIONS; HUMANS; PATIENT COMPLIANCE; STEREOTYPING;

EID: 84902319212     PISSN: 00207489     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijnurstu.2014.01.015     Document Type: Review

References (120)

1. Adewuya A.O., Afolabi M.O., Ola B.A., Ogundele O.A., Ajibare A.O., Oladipo B.F., Fakande I. Post-traumatic stress disorder (PTSD) after stigma related events in HIV infected individuals in Nigeria. Social Psychiatry and Psychiatric Epidemiology 2009, 44(9):761-766.
2. Adewuya A.O., Afolabi M.O., Ola B.A., Ogundele O.A., Ajibare A.O., Oladipo B.F., Fakande I. Relationship between depression and quality of life in persons with HIV infection in Nigeria. International Journal of Psychiatry in Medicine 2008, 38(1):43-51.
3. Alciati A., Starace F., Scaramelli B., Campaniello M., Adriani B., Mellado C., Cargnel A. Has there been a decrease in the prevalence of mood disorders in HIV-seropositive individuals since the introduction of combination therapy?. European Psychiatry 2001, 16(8):491-496.
4. Ammassari A., Antinori A., Aloisi M.S., Trotta M.P., Murri R., Bartoli L., Monforte A.D.A., Wu A.W., Starace F. Depressive symptoms, neurocognitive impairment, and adherence to highly active antiretroviral therapy among HIV-infected persons. Psychosomatics: Journal of Consultation Liaison Psychiatry 2004, 45(5):394-402.
5. Amoran O., Lawoyin T., Lasebikan V. Prevalence of depression among adults in Oyo State Nigeria: a comparative study of rural and urban communities. Australian Journal of Rural Health 2007, 15(3):211-215.
6. Anderson R.J., Freedland K.E., Clouse R.E., Lustman P.J. The prevalence of comorbid depression in adults with diabetes: a meta-analysis. Diabetes Care 2001, 24(6):1069-1078.
7. Bangsberg D.R., Hecht F.M., Charlebois E.D., Zolopa A.R., Holodniy M., Sheiner L., Bamberger J.D., Chesney M.A., Moss A. Adherence to protease inhibitors, HIV-1 viral load, and development of drug resistance in an indigent population. AIDS 2000, 14(4):357-366.
8. Bangsberg D.R., Perry S., Charlebois E.D., Clark R.A., Roberston M., Zolopa A.R., Moss A. Non-adherence to highly active antiretroviral therapy predicts progression to AIDS. AIDS 2001, 15(9):1181-1183.
9. Baxter A.J., Scott K.M., Vos T., Whiteford H.A. Global prevalence of anxiety disorders: a systematic review and meta-regression. Psychological Medicine 2012, 1-14.
10. Bayon C., Ribera E., Cabrero E., Griffa L., Burgos A. Prevalence of depressive and other central nervous system symptoms in HIV-infected patients treated with HAART in Spain. Journal of the International Association of Physicians in AIDS Care 2012, 11(5):321-328.
11. Bhat A.G., Babu R., Abhishekh H.A. Prevalence of depression among HIV patients on antiretroviral therapy: a study from India. Asian Journal of Psychiatry 2013, 6(3):249-250.
12. Bhengu B.R., Ncama B.P., McInerney P.A., Wantland D.J., Nicholas P.K., Corless I.B., McGibbon C.A., Davis S.M., Nicholas T.P., Ros A.V. Symptoms experienced by HIV-infected Individuals on antiretroviral therapy in KwaZulu-Natal, South Africa. Applied Nursing Research 2011, 24(1):1-9.
13. Boarts J.M., Bogart L.M., Tabak M.A., Armelie A.P., Delahanty D.L. Relationship of race-, sexual orientation-, and HIV-related discrimination with adherence to HIV treatment: a pilot study. Journal of Behavioral Medicine 2008, 31(5):445-451.
14. Boarts J.M., Sledjeski E.M., Bogart L.M., Delahanty D.L. The differential impact of PTSD and depression on HIV disease markers and adherence to HAART in people living with HIV. AIDS and Behavior 2006, 10(3):253-261.
15. Bogart L.M., Wagner G.J., Galvan F.H., Klein D.J. Longitudinal relationships between antiretroviral treatment adherence and discrimination due to HIV-serostatus, race, and sexual orientation among African-American men with HIV. Annals of Behavioral Medicine 2010, 40(2):184-190.
16. Bongongo T., Tumbo J., Govender I. Depressive features among adult patients receiving antiretroviral therapy for HIV in Rustenburg district, SA. South African Journal of Psychiatry 2013, 19(2):31-34.
17. Bouhnik A.D., Preau M., Vincent E., Carrieri M.P., Gallais H., Lepeu G., Gastaut J.A., Moatti J.P., Spire B., Group M.S. Depression and clinical progression in HIV-infected drug users treated with highly active antiretroviral therapy. Antiviral Therapy 2005, 10(1):53-61.
18. Braganca M., Palha A. Depression and neurocognitive performance in Portuguese patients infected with HIV. AIDS and Behavior 2011, 15(8):1879-1887.
19. Brandt R. The mental health of people living with HIV/AIDS in Africa: a systematic review. African Journal of AIDS Research 2009, 8(2):123-133.
20. Buathong N., Hiransuthikula N., Tangwongchaib S., Komoltric C. Association between depression and adherence to highly active antiretroviral therapy among adult HIV infected patients in Thailand. Asian Biomedicine 2009, 3(2):127-133.
21. Campbell C., Deacon H. Unravelling the contexts of stigma: from internalisation to resistance to change. Journal of Community & Applied Social Psychology 2006, 16(6):411-417.
22. Campbell C., Nair Y., Maimane S., Nicholson J. 'Dying twice': a multi-level model of the roots of AIDS stigma in two South African communities. Journal of Health Psychology 2007, 12(3):403-416.
23. Campbell C., Skovdal M., Madanhire C., Mugurungi O., Gregson S., Nyamukapa C. "We, the AIDS people. . .": how antiretroviral therapy enables Zimbabweans living with AIDS to cope with stigma. American Journal of Public Health 2011, 101(6):1004.
24. Campos L.N., Cesar C.C., Guimaraes M.D. Quality of life among HIV-infected patients in Brazil after initiation of treatment. Clinics (Sao Paulo, Brazil) 2009, 64(9):867-875.
25. Cha E., Erlen J.A., Kim K.H., Sereika S.M., Caruthers D. Mediating roles of medication-taking self-efficacy and depressive symptoms on self-reported medication adherence in persons with HIV: a questionnaire survey. International Journal of Nursing Studies 2008, 45(8):1175-1184.
26. Chiu E. Epidemiology of depression in the Asia Pacific region. Australas Psychiatry 2004, 12(Suppl.):S4-S10.
27. Clarke D.M., Currie K.C. Depression, anxiety and their relationship with chronic diseases: a review of the epidemiology, risk and treatment evidence. Medical Journal of Australia 2009, 190(7 Suppl.):S54-S60.
28. Clarke T.R., Gibson R.C., Barrow G., Abel W.D., Barton E.N. Depression among persons attending a HIV/AIDS outpatient clinic in Kingston, Jamaica. West Indian Medical Journal 2010, 59(4):369-373.
29. Clucas C., Sibley E., Harding R., Liu L., Catalan J., Sherr L. A systematic review of interventions for anxiety in people with HIV. Psychology, Health & Medicine 2011, 16(5):528-547.
30. Cohen M.H., Fabri M., Cai X., Shi Q., Hoover D.R., Binagwaho A., Culhane M.A., Mukanyonga H., Davis K.K., Anastos K. Prevalence and predictors of posttraumatic stress disorder and depression in HIV-infected and at-risk Rwandan women. Journal of Women's Health 2009, 18(11):1783-1791.
31. Das S., Leibowitz G.S. Mental health needs of people living with HIV/AIDS in India: a literature review. AIDS Care 2011, 23(4):417-425.
32. Dasgupta S., Sullivan P.S., Dasgupta A., Saha B., Salazar L.F. Stigma and access to HIV care among HIV-infected women in Kolkata, West Bengal. Journal of the International Association of Providers of AIDS Care 2013, 12(1):44-49.
33. De A.K., Dalui A. Assessment of factors influencing adherence to anti-retroviral therapy for human immunodeficiency virus positive mothers and their infected children. Indian Journal of Medical Sciences 2012, 66(11):247-259.
34. de Souza P.R.B., Szwarcwald C.L., de Castilho E.A. Self-rated health by HIV-infected individuals undergoing antiretroviral therapy in Brazil. Cadernos De Saude Publica 2011, 27:S56-S66.
35. Deacon H. Towards a sustainable theory of health-related stigma: lessons from the HIV/AIDS literature. Journal of Community and Applied Social Psychology 2006, 16:418-425.
36. Do H.M., Dunne M.P., Kato M., Pham C.V., Nguyen K.V. Factors associated with suboptimal adherence to antiretroviral therapy in Viet Nam: a cross-sectional study using audio computer-assisted self-interview (ACASI). BMC Infectious Diseases 2013, 13(1).
37. Do N.T., Phiri K., Bussmann H., Gaolathe T., Marlink R.G., Wester C.W. Psychosocial factors affecting medication adherence among HIV-1 infected adults receiving combination antiretroviral therapy (cART) in Botswana. AIDS Research and Human Retroviruses 2010, 26(6):685-691.
38. Edelman E.J., Gordon K., Justice A.C. Patient and provider-reported symptoms in the post-cART era. AIDS & Behavior 2011, 15(4):853-861.
39. Edelman E.J., Gordon K., Rodriguez-Barradas M.C. Patient-reported symptoms on the antiretroviral regimen efavirenz/emtricitabine/tenofovir. AIDS Patient Care and STDs 2012, 26(6):312-319.
40. Farrant L., Gwyther L., Dinat N., Mmoledi K., Hatta N., Harding R. The prevalence and burden of pain and other symptoms among South Africans attending highly active antiretroviral therapy (HAART) clinics. South African Medical Journal. Suid-Afrikaanse Tydskrif Vir Geneeskunde 2012, 102(6):499-500.
41. Ferrari A.J., Charlson F.J., Norman R.E., Patten S.B., Freedman G., Murray C.J., Vos T., Whiteford H.A. Burden of depressive disorders by country, sex, age, and year: findings from the Global Burden of Disease Study 2010. PLoS Medicine 2013, 10(11):e1001547.
42. Fiest K.M., Dykeman J., Patten S.B., Wiebe S., Kaplan G.G., Maxwell C.J., Bulloch A.G., Jette N. Depression in epilepsy: a systematic review and meta-analysis. Neurology 2012, 80(6):590-599.
43. Garvie P.A., Flynn P.M., Belzer M., Britto P., Hu C., Graham B., Neely M., McSherry G.D., Spector S.A., Gaur A.H. Psychological factors, beliefs about medication, and adherence of youth with human immunodeficiency virus in a multisite directly observed therapy pilot study. Journal of Adolescent Health 2011, 48(6):637-640.
44. Gaynes B.N., Pence B.W., Atashili J., O'Donnell J., Kats D., Ndumbe P.M. Prevalence and predictors of major depression in HIV-infected patients on antiretroviral therapy in Bamenda, a semi-urban center in Cameroon. PLoS ONE 2012, 7(7).
45. Gibbie T., Mijch A., Ellen S., Hoy J., Hutchison C., Wright E., Chua P., Judd F. Depression and neurocognitive performance in individuals with HIV/AIDS: 2-year follow-up. HIV Medicine 2006, 7(2):112-121.
46. Goffman E. Stigma. Notes on the Management of Spoiled Identity 1963, Prentice-Hall, New Jersey, USA.
47. Gonzalez J.S., Batchelder A.W., Psaros C., Safren S.A. Depression and HIV/AIDS treatment nonadherence: a review and meta-analysis. Journal of Acquired Immune Deficiency Syndromes 2011, 58(2):181-187.
48. Gonzalez J.S., Psaros C., Batchelder A., Applebaum A., Newville H., Safren S.A. Clinician-assessed depression and HAART adherence in HIV-infected individuals in methadone maintenance treatment. Annals of Behavioral Medicine 2011, 42(1):120-126.
49. Gordillo V., Del Amo J., Soriano V., Gonzalez-Lahoz J. Sociodemographic and psychological variables influencing adherence to antiretroviral therapy. AIDS 1999, 13(13):1763-1769.
50. Harding R., Karus D., Easterbrook P., Raveis V.H., Higginson I.J., Marconi K. Does palliative care improve outcomes for patients with HIV/AIDS? A systematic review of the evidence. Sexually Transmitted Infections 2005, 81(1):5-14.
51. Harding R., Molloy T., Easterbrook P., Frame K., Higginson I.J. Is antiretroviral therapy associated with symptom prevalence and burden?. International Journal of STD and AIDS 2006, 17(6):400-405.
52. Health N.I.o.M. Anxiety Disorders 2013.
53. HSCIC Adult Psychiatric Morbidity in England - 2007. Results of a Household Survey. Health and Social Care Information Centre, Government of the United Kingdom 2009.
54. International Planned Parenthood Federation U. The People Living with HIV Stigma Index 2008, IPPF, London.
55. Judd F., Komiti A., Chua P., Mijch A., Hoy J., Grech P., Street A., Lloyd J., Williams B. Nature of depression in patients with HIV/AIDS. Australian and New Zealand Journal of Psychiatry 2005, 39(9):826-832.
56. Keltner J.R., Vaida F., Ellis R.J., Moeller-Bertram T., Fitzsimmons C., Duarte N.A., Robinson-Papp J., Dworkin R.H., Clifford D.B., McArthur J.C., Simpson D.M., Collier A.C., Marra C.M., Atkinson J., Grant I. Health-related quality of life 'well-being' in HIV distal neuropathic pain is more strongly associated with depression severity than with pain intensity. Psychosomatics: Journal of Consultation Liaison Psychiatry 2012, 53(4):380-386.
57. Kessler R.C., Chiu W.T., Demler O., Merikangas K.R., Walters E.E. Prevalence, severity, and comorbidity of 12-month DSM-IV disorders in the National Comorbidity Survey Replication. Archives of General Psychiatry 2005, 62(6):617-627.
58. Knowlton A.R., Yang C., Bohnert A., Wissow L., Chander G., Arnsten J.A. Informal care and reciprocity of support are associated with HAART adherence among men in Baltimore, MD, USA. AIDS and Behavior 2011, 15(7):1429-1436.
59. Kong M.C., Nahata M.C., Lacombe V.A., Seiber E.E., Balkrishnan R. Association between race, depression, and antiretroviral therapy adherence in a low-income population with HIV infection. Journal of General Internal Medicine 2012, 27(9):1159-1164.
60. Lawler K., Mosepele M., Seloilwe E., Ratcliffe S., Steele K., Nthobatsang R., Steenhoff A. Depression among HIV-positive individuals in Botswana: a behavioral surveillance. AIDS and Behavior 2011, 15(1):204-208.
61. Loney P.L., Chambers L.W., Bennett K.J., Roberts J.G., Stratford P.W. Critical appraisal of the health research literature: prevalence or incidence of a health problem. Chronic Diseases in Canada 1998, 19(4):170-176.
62. Michel L., Villes V., Dabis F., Spire B., Winnock M., Loko M.A., Poizot-Martin I., Valantin M.A., Bonnard P., Salmon-Ceron D., Carrieri M.P. Role of treatment for depressive symptoms in relieving the impact of fatigue in HIV-HCV co-infected patients: ANRS Co13 Hepavih, France, 2006-2008. Journal of Viral Hepatitis 2010, 17(9):650-660.
63. Moher D., Liberati A., Tetzlaff J., Altman D.G., Group P. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. Journal of Clinical Epidemiology 2009, 62(10):1006-1012.
64. Nakimuli-Mpungu E., Mojtabai R., Alexandre P.K., Musisi S., Katabira E., Nachega J.B., Treisman G., Bass J.K. Lifetime depressive disorders and adherence to anti-retroviral therapy in HIV-infected Ugandan adults: a case-control study. Journal of Affective Disorders 2013, 145(2):221-226.
65. Nakimuli-Mpungu E., Musisi S., Katabira E., Nachega J., Bass J. Prevalence and factors associated with depressive disorders in an HIV+ rural patient population in southern Uganda. Journal of Affective Disorders 2011, 135(1-3):160-167.
66. Nel A., Kagee A. The relationship between depression, anxiety and medication adherence among patients receiving antiretroviral treatment in South Africa. AIDS Care - Psychological and Socio-Medical Aspects of AIDS/HIV 2013, 25(8):948-955.
67. NHS Undertaking Systematic Reviews of Research on Effectiveness 1996, York Publishing Services, York.
68. Nozaki I., Dube C., Kakimoto K., Yamada N., Simpungwe J.B. Social factors affecting ART adherence in rural settings in Zambia. AIDS Care - Psychological and Socio-Medical Aspects of AIDS/HIV 2011, 23(7):831-838.
69. Nurutdinova D., Chrusciel T., Zeringue A., Scherrer J.F., Al-Aly Z., McDonald J.R., Overton E.T. Mental health disorders and the risk of AIDS-defining illness and death in HIV-infected veterans. AIDS 2012, 26(2):229-234.
70. Nyamathi A., Ekstrand M., Salem B.E., Sinha S., Ganguly K.K., Leake B. Impact of Asha Intervention on Stigma Among Rural Indian Women With AIDS. Western Journal of Nursing Research 2013, 35(7):867-883.
71. Nyblade L.C. Measuring HIV stigma: existing knowledge and gaps. Psychology, Health & Medicine 2006, 11(3):335-345.
72. Olagunju A.T., Adeyemi J.D., Ogbolu R.E., Campbell E.A. A study on epidemiological profile of anxiety disorders among people living with HIV/AIDS in a sub-Saharan Africa HIV clinic. AIDS and Behavior 2012, 16(8):2192-2197.
73. Olisah V.O., Baiyewu O., Sheikh T.L. Depression under diagnosis and the effects on quality of life in outpatients with HIV at a Nigerian university teaching hospital. AJAR-African Journal of AIDS Research 2011, 10(3):247-254.
74. ONS United Kingdom Health Statistics 2010. Office for National Statistics 2010.
75. Owolabi R.S., Araoye M.O., Osagbemi G.K., Odeigah L., Ogundiran A., Hussain N.A. Assessment of stigma and discrimination experienced by people living with HIV and AIDS receiving care/treatment in University of Ilorin Teaching Hospital (UITH), Ilorin, Nigeria. Journal of the International Association of Physicians in AIDS Care 2012, 11(2):121-127.
76. Palmer A.K., Duncan K.C., Ayalew B., Zhang W., Tzemis D., Lima V., Montaner J.S., Hogg R.S. "The way I see it": the effect of stigma and depression on self-perceived body image among HIV-positive individuals on treatment in British Columbia, Canada. AIDS Care 2011, 23(11):1456-1466.
77. Pappin M., Wouters E., Booysen F.L. Anxiety and depression amongst patients enrolled in a public sector antiretroviral treatment programme in South Africa: a cross-sectional study. BMC Public Health 2012, 12:244.
78. Parker R. Stigma, prejudice and discrimination in global public health. Cadernos de Saúde Pública 2012, 28(1):164-169.
79. Parker R., Aggleton P. HIV and AIDS-related stigma and discrimination: a conceptual framework and implications for action. Social Science & Medicine 2003, 57(1):13-24.
80. Patten S.B., Beck C.A., Williams J.V., Barbui C., Metz L.M. Major depression in multiple sclerosis: a population-based perspective. Neurology 2003, 61(11):1524-1527.
81. PEPFAR HIV/AIDS Palliative Care Guidance #1: For the United States Government in-Country Staff and Implementing Partners 2006, 17.
82. Peretti-Watel P., Spire B., Pierret J., Lert F., Obadia Y. Management of HIV-related stigma and adherence to HAART: evidence from a large representative sample of outpatients attending French hospitals (ANRS-EN12-VESPA 2003). AIDS Care - Psychological and Socio-Medical Aspects of AIDS/HIV 2006, 18(3):254-261.
83. Peterson K., Togun T., Klis S., Menten J., Colebunders R. Depression and posttraumatic stress disorder among HIV-infected Gambians on antiretroviral therapy. AIDS Patient Care & STDs 2012, 26(10):589-596.
84. Poupard M., Gueye N.F.N., Thiam D., Ndiaye B., Girard P.M., Delaporte E., Sow P.S., Landman R. Quality of life and depression among HIV-infected patients receiving efavirenz- or protease inhibitor-based therapy in Senegal. HIV Medicine 2007, 8(2):92-95.
85. Pumpradit W., Ananworanich J., Lolak S., Shikuma C., Paul R., Siangphoe U., Chaoniti N., Kaew-On P., Paris R., Ruxrungtham K., Valcour V. Neurocognitive impairment and psychiatric comorbidity in well-controlled human immunodeficiency virus infected Thais from the 2NN Cohort Study. Journal of Neurovirology 2010, 16(1):76-82.
86. Rabkin J.G., Ferrando S.J., Van Gorp W., Rieppi R., McElhiney M., Sewell M. Relationships among apathy, depression, and cognitive impairment in HIV/AIDS. Journal of Neuropsychiatry and Clinical Neurosciences 2000, 12(4):451-457.
87. Roge B.T., Barfod T.S., Kirk O., Katzenstein T.L., Obel N., Nielsen H., Pedersen C., Mathiesen L.R., Lundgren J.D., Gerstoft J. Resistance profiles and adherence at primary virological failure in three different highly active antiretroviral therapy regimens: analysis of failure rates in a randomized study. HIV Medicine 2004, 5(5):344-351.
88. Roux P., Carrieri M.P., Michel L., Fugon L., Marcellin F., Obadia Y., Spire B. Effect of anxiety symptoms on adherence to highly active antiretroviral therapy in HIV-infected women. Journal of Clinical Psychiatry 2009, 70(9):1328.
89. Sarna A., Pujari S., Sengar A.K., Garg R., Gupta I., Dam J. Adherence to antiretroviral therapy & its determinants amongst HIV patients in India. Indian Journal of Medical Research 2008, 127(1):28-36.
90. Schoesson L.N., Williams M.L., Ross M.W., Bratt G., Keel B. Factors associated with suboptimal antiretroviral therapy adherence to dose, schedule, and dietary instructions. AIDS and Behavior 2007, 11(2):175-183.
91. Sherr L., Clucas C., Harding R., Sibley E., Catalan J. HIV and depression - a systematic review of interventions. Psychology, Health & Medicine 2011, 16(5):493-527.
92. Silveira M.P.T., Guttier M.C., Pinheiro C.A.T., Pereira T.V.S., Cruzeiro A.L.S., Moreira L.B. Depressive symptoms in HIV-infected patients treated with highly active antiretroviral therapy. Revista Brasileira De Psiquiatria 2012, 34(2):162-167.
93. Simbayi L.C., Kalichman S., Strebel A., Cloete A., Henda N., Mqeketo A. Internalized stigma, discrimination, and depression among men and women living with HIV/AIDS in Cape Town, South Africa. Social Science & Medicine 2007, 64(9):1823-1831.
94. Simms V., Higginson I.J., Harding R. Integration of palliative care throughout HIV disease. The Lancet Infectious Diseases 2012, 12(7):571-575.
95. Simoni J.M., Pantalone D.W., Plummer M.D., Huang B. A randomized controlled trial of a peer support intervention targeting antiretroviral medication adherence and depressive symptomatology in HIV-positive men and women. Health Psychology 2007, 26(4):488-495.
96. Starace F., Bartoli L., Aloisi M., Antinori A., Narciso P., Ippolito G., Ravasio L., Moioli M., Vangi D., Gennero L., Coronado O., Giacometti A., Nappa S., Perulli M., Montesarchio V., La Gala A., Ricci F., Cristiano L., De Marco M., Izzo C., Pezzotti P., Monforte A. Cognitive and affective disorders associated to HIV infection in the HAART era: findings form the NeuroICONA study: cognitive impairment and depression in HIV/AIDS - the NeuroICONA study. Acta Psychiatrica Scandinavica 2002, 106(1):20-26.
97. Steward W.T., Herek G.M., Ramakrishna J., Bharat S., Chandy S., Wrubel J., Ekstrand M.L. HIV-related stigma: adapting a theoretical framework for use in India. Social Science & Medicine 2008, 67(8):1225-1235.
98. Stutterheim S.E., Pryor J.B., Bos A.E., Hoogendijk R., Muris P., Schaalma H.P. HIV-related stigma and psychological distress: the harmful effects of specific stigma manifestations in various social settings. AIDS 2009, 23(17):2353-2357.
99. Sumari-de Boer I., Sprangers M.A., Prins J.M., Nieuwkerk P.T. HIV stigma and depressive symptoms are related to adherence and virological response to antiretroviral treatment among immigrant and indigenous HIV infected patients. AIDS and Behavior 2012, 16(6):1681-1689.
100. Tomlinson M., Grimsrud A.T., Stein D.J., Williams D.R., Myer L. The epidemiology of major depression in South Africa: results from the South African stress and health study. South African Medical Journal 2009, 99(5 Pt 2):367-373.
101. Tucker J.S., Burnam M.A., Sherbourne C.D., Kung F.Y., Gifford A.L. Substance use and mental health correlates of nonadherence to antiretroviral medications in a sample of patients with human immunodeficiency virus infection. American Journal of Medicine 2003, 114(7):573-580.
102. Turan J.M., Bukusi E.A., Onono M., Holzemer W.L., Miller S., Cohen C.R. HIV/AIDS stigma and refusal of HIV testing among pregnant women in rural Kenya: results from the MAMAS study. AIDS and Behavior 2011, 15(6):1111-1120.
103. UCAID Care and Support. The Forgotten Pillar of the HIV response 2011, 1-41. London.
104. UNAIDS AIDS: Palliative Care. Technical Update 2000, UNAIDS, Geneva.
105. UNAIDS Getting to Zero. UNAIDS Strategy 2011-2015 2010, WHO.
106. UNAIDS UNAIDS Report on the Global AIDS Epidemic 2010.
107. UNAIDS UNAIDS Terminology Guidelines 2011, UNAIDS, New York.
108. Wagner G.J., Goggin K., Remien R.H., Rosen M.I., Simoni J., Bangsberg D.R., Liu H. A closer look at depression and its relationship to HIV antiretroviral adherence. Annals of Behavioral Medicine 2011, 42(3):352-360.
109. WHO Antiretroviral Therapy for HIV Infection in Adults and Adolescents. Recommendations for a Public Health Approach 2010, Geneva.
110. WHO A Community Health Approach to Palliative Care for HIV/AIDS and Cancer Patients in Sub Saharan Africa 2004, WHO, Geneva.
111. WHO Consolidated Guidelines on General HIV Care and the Use of Antiretroviral Drugs for Treating and Preventing HIV Infection: Recommendations for a Public Health Approach 2013, WHO, Geneva, Switzerland, 272 pp.
112. WHO Constitution of the World Health Organisation 1948, WHO, New York.
113. WHO Depression. Fact Sheet No. 369 2012.
114. WHO Psychosocial Support 2012.
115. Wolfe W.R., Weiser S.D., Bangsberg D.R., Thior I., Makhema J.M., Dickinson D.B., Mompati K.F., Marlink R.G. Effects of HIV-related stigma among an early sample of patients receiving antiretroviral therapy in Botswana. AIDS Care 2006, 18(8):931-933.
116. Wolitski R.J., Pals S.L., Kidder D.P., Courtenay-Quirk C., Holtgrave D.R. The effects of HIV stigma on health disclosure of HIV status, and risk behavior of homeless and unstably housed persons living with HIV. AIDS and Behavior 2009, 13(6):1222-1232.
117. WorldBank Country and Lending Groups 2012.
118. Wouters E., Booysen Fle R., Ponnet K., Baron Van Loon F. Wording effects and the factor structure of the Hospital Anxiety & Depression Scale in HIV/AIDS patients on antiretroviral treatment in South Africa. PLoS ONE [Electronic Resource] 2012, 7(4):e34881.
119. Yen C.F., Tsai J.J., Lu P.L., Chen Y.H., Chen T.C., Chen P.P., Chen T.P. Quality of life and its correlates in HIV/AIDS male outpatients receiving highly active antiretroviral therapy in Taiwan. Psychiatry and Clinical Neurosciences 2004, 58(5):501-506.
120. Zhang W., O'Brien N., Forrest J.I., Salters K.A., Patterson T.L., Montaner J.S., Hogg R.S., Lima V.D. Validating a shortened depression scale (10 item CES-D) among HIV-positive people in British Columbia, Canada. PLoS ONE [Electronic Resource] 2012, 7(7):e40793.